COSCIENS Biopharma Inc.
CSCI
$3.00
$0.072.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.70M | -3.66M | -6.73M | -1.42M | -1.42M |
| Total Depreciation and Amortization | 287.00K | 325.00K | 392.00K | 377.00K | 377.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 392.00K | 123.00K | 2.59M | -2.16M | -2.16M |
| Change in Net Operating Assets | -2.43M | 1.33M | 754.00K | 1.82M | 1.82M |
| Cash from Operations | -4.45M | -1.88M | -3.00M | -1.39M | -1.39M |
| Capital Expenditure | -49.00K | -615.00K | -309.00K | -157.00K | -157.00K |
| Sale of Property, Plant, and Equipment | 1.00K | 4.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 26.04M | 26.04M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -4.00K | -7.00K | -- | -- |
| Cash from Investing | -48.00K | -615.00K | -316.00K | 25.88M | 25.88M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -65.00K | -200.00K | -109.00K | -126.00K | -126.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -42.00K | -- | -93.00K | -- | -- |
| Cash from Financing | -107.00K | -200.00K | -202.00K | -126.00K | -126.00K |
| Foreign Exchange rate Adjustments | 177.00K | 60.00K | -88.00K | -67.00K | -67.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.43M | -2.64M | -3.61M | 24.30M | 24.30M |